{"id":177425,"date":"2011-01-11T00:00:00","date_gmt":"2011-01-10T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/informations-recentes-janvier-2011-version-adaptee-le-31-01-2011\/"},"modified":"2026-04-02T19:11:58","modified_gmt":"2026-04-02T17:11:58","slug":"informations-recentes-janvier-2011-version-adaptee-le-31-01-2011","status":"publish","type":"post","link":"https:\/\/cbip.be\/fr\/informations-recentes-janvier-2011-version-adaptee-le-31-01-2011\/","title":{"rendered":"INFORMATIONS RECENTES JANVIER 2011 (version adapt\u00e9e le 31\/01\/2011)"},"content":{"rendered":"<div class='tekst'>\n<p class='MsoNormal' style='margin: 0cm 0cm 0pt; line-height: 200%'><span lang='FR' style='font-family: Arial'><\/p>\n<p>\u00a0<\/p>\n<p><\/span><\/p>\n<div style='border-right: windowtext 1pt solid; padding-right: 4pt; border-top: windowtext 1pt solid; padding-left: 4pt; padding-bottom: 1pt; border-left: windowtext 1pt solid; padding-top: 1pt; border-bottom: windowtext 1pt solid'>\n<p class='MsoNormal' style='border-right: medium none; padding-right: 0cm; border-top: medium none; padding-left: 0cm; padding-bottom: 0cm; margin: 0cm 0cm 0pt; border-left: medium none; line-height: 200%; padding-top: 0cm; border-bottom: medium none'><b><span lang='FR' style='line-height: 200%' wingdings=''><span><img height='10' alt='' width='10' border='0' src='\/images\/surv.gif'\/><\/span><\/span><\/b><b><span lang='FR' style='line-height: 200%; font-family: Arial; letter-spacing: 1pt'>: m\u00e9dicament \u00e0 base d\u2019un nouveau principe actif ou nouveau m\u00e9dicament biologique&#x002C; pour lequel la notification d\u2019effets ind\u00e9sirables au Centre Belge de Pharmacovigilance est encourag\u00e9e<\/span><\/b><span lang='FR' style='line-height: 200%; font-family: Arial; letter-spacing: 1pt'><\/p>\n<p\/><\/span><\/p>\n<\/p><\/div>\n<p class='MsoNormal' style='margin: 0cm 0cm 0pt; line-height: 200%'><span lang='FR' style='font-family: Arial'><\/p>\n<p>\u00a0<\/p>\n<p><\/span><\/p>\n<p class='MsoNormal' style='margin: 0cm 0cm 0pt; line-height: 200%'><span lang='FR' style='font-family: Arial'>&#8211; La <b>corifollitropine alfa<\/b> (<b>Elonva<\/b> <\/span>\u00ae<span lang='FR' wingdings=''><span><img height='10' alt='' width='10' border='0' src='\/images\/surv.gif'\/><\/span><\/span><span lang='FR' style='font-family: Arial'>\u00a0; chapitre 7.3.9.1.) est une hormone folliculostimulante biosynth\u00e9tique propos\u00e9e dans la stimulation ovarienne contr\u00f4l\u00e9e dans le cadre de la procr\u00e9ation m\u00e9dicalement assist\u00e9e. Son profil pharmacologique est comparable \u00e0 celui de la FSH&#x002C; mais sa dur\u00e9e d\u2019action est nettement plus longue (dur\u00e9e de \u00bd vie de 69h)&#x002C;<span>\u00a0 <\/span>de sorte que la corifollitropine alfa peut \u00eatre administr\u00e9e en une seule injection sous-cutan\u00e9e (au lieu d\u2019injections de FSH pendant 7 jours).<span>\u00a0 <\/span>Son efficacit\u00e9 et ses effets ind\u00e9sirables paraissent comparables \u00e0 celles de la FSH&#x002C; bien qu\u2019une augmentation l\u00e9g\u00e8re mais non significative de\u00a0 l&rsquo;incidence d\u2019hyperstimulation ovarienne (caract\u00e9rise entre autres par des douleurs abdominales&#x002C; des naus\u00e9es&#x002C; de la diarrh\u00e9e&#x002C; des kystes ovariens&#x002C; de l\u2019ascite et une prise de poids) ait \u00e9t\u00e9 observ\u00e9e dans une \u00e9tude randomis\u00e9e. <\/p>\n<p\/><\/span><\/p>\n<p class='MsoNormal' style='margin: 0cm 0cm 0pt; line-height: 200%'><span lang='FR' style='font-family: Arial'>&#8211; <small>[Texte adapt\u00e9 le 31\/01\/2011]<\/small> La production de la sp\u00e9cialit\u00e9 <b>Algophene<\/b><\/span>\u00ae<span lang='FR' style='font-family: Arial'> (chapitre 5.4.2.)&#x002C; \u00e0 base de dextropropoxyph\u00e8ne et de parac\u00e9tamol est arr\u00eat\u00e9e. La sp\u00e9cialit\u00e9 peut encore \u00eatre vendue jusqu&rsquo;\u00e0 \u00e9puisement des stocks&#x002C; et sera retir\u00e9e du march\u00e9 au plus tard en septembre 2011.<span>\u00a0 <\/span>L\u2019Agence europ\u00e9enne des m\u00e9dicaments (EMA) avait recommand\u00e9 le retrait des m\u00e9dicaments \u00e0 base de dextropropoxyph\u00e8ne en raison de sa balance b\u00e9n\u00e9fices-risques jug\u00e9e n\u00e9gative&#x002C; surtout en raison de la marge th\u00e9rapeutique-toxique \u00e9troite et du risque d\u2019\u00e9volution fatale en cas de surdosage <\/span><span lang='FR' style='font-family: Symbol'><span>[<\/span><\/span><span lang='FR' style='font-family: Arial'>voir Folia d\u2019ao\u00fbt 2009<\/span><span lang='FR' style='line-height: 200%; font-family: Arial; letter-spacing: 1pt'>]. <\/span><span lang='FR' style='font-family: Arial'><\/p>\n<p\/><\/span><\/p>\n<p>\u00a0<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 : m\u00e9dicament \u00e0 base d\u2019un nouveau principe actif ou  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,52],"tags":[20213,20224],"class_list":["post-177425","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2011-fr","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=177425"}],"version-history":[{"count":1,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177425\/revisions"}],"predecessor-version":[{"id":179999,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177425\/revisions\/179999"}],"wp:attachment":[{"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=177425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=177425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=177425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}